Logotipo do repositório
 

Publicação:
In vitro evaluation of the safety profile of cosmeceuticals containing growth factors and their analogues

dc.contributor.authorDieamant, Gustavo
dc.contributor.authorCosta, Adilson
dc.contributor.authorBechelli, Liliana
dc.contributor.authorTibério, Juliana [UNESP]
dc.contributor.authorPereira, Carolina
dc.contributor.institutionPesquisa e Desenvolvimento da Chemyunion Química Ltda.
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionPontifícia Universidade Católica de Campinas (PUCCampinas)
dc.contributor.institutionUniversiteit Brussel- Bélgica
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionChemyunion Química Ltda.
dc.contributor.institutionKOLderma Instituto de Pesquisa Clínica Ltda.
dc.date.accessioned2022-04-29T06:48:18Z
dc.date.available2022-04-29T06:48:18Z
dc.date.issued2012-12-01
dc.description.abstractIntroduction: Aging skin is a condition that affects (or will affect) all people, and its treatment is considered a clinical challenge. Growth factors and their analogues are emerging as a promising therapeutic option. Objectives: To evaluate the safety profile of some dermocosmetic products with formulations based on growth factors - or their analogs intended for that purpose - using in vitro human skin cell culture models. Methods: Two types of cell cultures were studied, and the effects of the study products on the proliferation of melanoma cells and normal human fibroblasts were evaluated. Results: No significant morphological alterations were found in the cultured human melanoma, and no significant decrease in the number of healthy cells was verified in the normal fibroblasts culture. In some cases there was even a proliferation of those cells. Conclusions: These preliminary data demonstrate that cosmeceutical products containing growth factors as an active principle can be considered safe for topical application. © Sociedade Brasileira de Dermatologia.en
dc.description.affiliationGerente de Tecnologia Pesquisa e Desenvolvimento da Chemyunion Química Ltda., Farmacologista/imunotoxicologista, Sorocaba/SP
dc.description.affiliationDermatologista Mestre em Dermatologia pela Universidade Federal de São Paulo Escola Paulista de Medicina (EPM/UNI FESP), São Paulo/SP
dc.description.affiliationDoutorando em Dermatologia pela Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo/SP
dc.description.affiliationCosmiatria, dermatologia na gravidez Vitiligo e pesquisa clínica em Dermatologia do Serviço de Dermatologia Pontifícia Universidade Católica de Campinas (PUCCampinas), Campinas/SP
dc.description.affiliationUniversiteit Brussel- Bélgica
dc.description.affiliationBiological Sciences (Pharmacology) Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu (SP)
dc.description.affiliationBiologist; Full Researcher R and D Department Chemyunion Química Ltda., Sorocaba (SP)
dc.description.affiliationPhysician; Dermatology Clinical Research intern KOLderma Instituto de Pesquisa Clínica Ltda., Campinas (SP)
dc.description.affiliationUnespBiological Sciences (Pharmacology) Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu (SP)
dc.format.extent2
dc.identifier.citationSurgical and Cosmetic Dermatology, v. 4, n. 3, p. 2-, 2012.
dc.identifier.issn1984-5510
dc.identifier.issn1984-8773
dc.identifier.scopus2-s2.0-84872868821
dc.identifier.urihttp://hdl.handle.net/11449/227112
dc.language.isoeng
dc.relation.ispartofSurgical and Cosmetic Dermatology
dc.sourceScopus
dc.subjectIntracellular signaling peptides and proteins
dc.subjectSkin
dc.subjectSkin aging
dc.titleIn vitro evaluation of the safety profile of cosmeceuticals containing growth factors and their analoguesen
dc.typeArtigo
dspace.entity.typePublication
unesp.campusUniversidade Estadual Paulista (UNESP), Instituto de Biociências, Botucatupt
unesp.departmentFarmacologia - IBBpt

Arquivos